Related Experiment Video
Updated: Apr 12, 2026
11:20
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
11.5K
Molecular markers: Implications for cytopathology and specimen collection
1Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Cancer Cytopathology
|May 13, 2015
Summary
Cytologic specimens are crucial for tumor diagnosis and molecular marker testing. Proper collection and processing ensure accurate results for personalized medicine.
Area of Science:
- Cytopathology
- Molecular Pathology
- Oncology
Background:
- Minimally invasive biopsy techniques yield cytologic specimens for tumor diagnosis.
- Ancillary molecular tests on these specimens have increased significantly.
- Molecular markers aid diagnosis, prognosis, and therapeutic decisions.
Purpose of the Study:
- To review effective cytologic specimen collection and processing for molecular marker studies.
- To provide an overview of molecular markers relevant to various tumor sites.
- To emphasize the role of cytopathologists in personalized medicine.
Main Methods:
- Literature review of cytologic specimen handling for molecular testing.
- Overview of established and emerging molecular markers for common tumor sites.
- Discussion of best practices for cytopathologists.
Main Results:
- Effective specimen collection and processing are vital for molecular testing success.
- A range of molecular markers are available for diverse tumor types.
- Cytopathologists play a key role in integrating molecular data into patient care.
Conclusions:
- Optimized cytologic specimen management is essential for molecular diagnostics.
- Understanding tumor-specific molecular markers is critical for cytopathologists.
- The integration of molecular pathology in cytopathology advances personalized cancer care.
